Investment Rating - The report maintains a "Buy" rating for the company [6]. Core Views - The company's performance exceeded expectations in Q3 2024, with continuous improvement in profitability compared to Q2, primarily due to an increase in gross margin [2][4]. - The company is expected to enhance its market share through customer expansion and scale effects, leading to further optimization of profitability [2]. Financial Summary - For the first three quarters of 2024, the company achieved revenue of 1.387 billion yuan, a year-on-year decrease of 3.79%. However, net profit attributable to shareholders was 32 million yuan, representing a year-on-year increase of 150% [4]. - In Q3 2024, revenue reached 528 million yuan, a year-on-year increase of 2.20%, marking the first positive growth in three years. The net profit attributable to shareholders for Q3 was 25 million yuan, reversing losses from the previous year [4]. - The gross margin for Q3 2024 was 18.94%, an increase of 6.44 percentage points year-on-year, attributed to lower raw material costs and reduced depreciation [4]. Category Performance - The skincare category continues to show growth, with significant recovery in the gross margin of facial masks. In H1 2024, revenue from the mask, skincare, and wet wipes segments was 372 million, 301 million, and 138 million yuan, respectively [5]. - The gross margins for these categories in H1 2024 were 15.30%, 14.76%, and 12.25%, reflecting improvements due to lower raw material costs and product mix adjustments [5]. Market Position - The company, as a leading domestic cosmetics OEM, is expected to capture market share amid industry consolidation, as many smaller brands face operational challenges [5]. - The report anticipates that the ongoing weak retail environment for cosmetics will accelerate the exit of smaller manufacturers, allowing the company to optimize its client structure and enhance market share [5].
青松股份2024年三季报点评:业绩超预期,需求、盈利双双改善